319 related articles for article (PubMed ID: 25307742)
1. Integrated control of hepatic lipogenesis versus glucose production requires FoxO transcription factors.
Haeusler RA; Hartil K; Vaitheesvaran B; Arrieta-Cruz I; Knight CM; Cook JR; Kammoun HL; Febbraio MA; Gutierrez-Juarez R; Kurland IJ; Accili D
Nat Commun; 2014 Oct; 5():5190. PubMed ID: 25307742
[TBL] [Abstract][Full Text] [Related]
2. Hepatic mTORC2 activates glycolysis and lipogenesis through Akt, glucokinase, and SREBP1c.
Hagiwara A; Cornu M; Cybulski N; Polak P; Betz C; Trapani F; Terracciano L; Heim MH; Rüegg MA; Hall MN
Cell Metab; 2012 May; 15(5):725-38. PubMed ID: 22521878
[TBL] [Abstract][Full Text] [Related]
3. Selective Inhibition of FOXO1 Activator/Repressor Balance Modulates Hepatic Glucose Handling.
Langlet F; Haeusler RA; Lindén D; Ericson E; Norris T; Johansson A; Cook JR; Aizawa K; Wang L; Buettner C; Accili D
Cell; 2017 Nov; 171(4):824-835.e18. PubMed ID: 29056338
[TBL] [Abstract][Full Text] [Related]
4. FoxO1 regulates multiple metabolic pathways in the liver: effects on gluconeogenic, glycolytic, and lipogenic gene expression.
Zhang W; Patil S; Chauhan B; Guo S; Powell DR; Le J; Klotsas A; Matika R; Xiao X; Franks R; Heidenreich KA; Sajan MP; Farese RV; Stolz DB; Tso P; Koo SH; Montminy M; Unterman TG
J Biol Chem; 2006 Apr; 281(15):10105-17. PubMed ID: 16492665
[TBL] [Abstract][Full Text] [Related]
5. FoxOs function synergistically to promote glucose production.
Haeusler RA; Kaestner KH; Accili D
J Biol Chem; 2010 Nov; 285(46):35245-8. PubMed ID: 20880840
[TBL] [Abstract][Full Text] [Related]
6. Hepatic suppression of Foxo1 and Foxo3 causes hypoglycemia and hyperlipidemia in mice.
Zhang K; Li L; Qi Y; Zhu X; Gan B; DePinho RA; Averitt T; Guo S
Endocrinology; 2012 Feb; 153(2):631-46. PubMed ID: 22147007
[TBL] [Abstract][Full Text] [Related]
7. A mutant allele encoding DNA binding-deficient FoxO1 differentially regulates hepatic glucose and lipid metabolism.
Cook JR; Matsumoto M; Banks AS; Kitamura T; Tsuchiya K; Accili D
Diabetes; 2015 Jun; 64(6):1951-65. PubMed ID: 25576059
[TBL] [Abstract][Full Text] [Related]
8. Bradykinin inhibits hepatic gluconeogenesis in obese mice.
Barros CC; Haro A; Russo FJ; Schadock I; Almeida SS; Reis FC; Moraes MR; Haidar A; Hirata AE; Mori M; Bacurau RF; Würtele M; Bader M; Pesquero JB; Araujo RC
Lab Invest; 2012 Oct; 92(10):1419-27. PubMed ID: 22868909
[TBL] [Abstract][Full Text] [Related]
9. Deletion of hepatic FoxO1/3/4 genes in mice significantly impacts on glucose metabolism through downregulation of gluconeogenesis and upregulation of glycolysis.
Xiong X; Tao R; DePinho RA; Dong XC
PLoS One; 2013; 8(8):e74340. PubMed ID: 24015318
[TBL] [Abstract][Full Text] [Related]
10. Identification of Akt-independent regulation of hepatic lipogenesis by mammalian target of rapamycin (mTOR) complex 2.
Yuan M; Pino E; Wu L; Kacergis M; Soukas AA
J Biol Chem; 2012 Aug; 287(35):29579-88. PubMed ID: 22773877
[TBL] [Abstract][Full Text] [Related]
11. Endurance exercise training increases APPL1 expression and improves insulin signaling in the hepatic tissue of diet-induced obese mice, independently of weight loss.
Marinho R; Ropelle ER; Cintra DE; De Souza CT; Da Silva AS; Bertoli FC; Colantonio E; D'Almeida V; Pauli JR
J Cell Physiol; 2012 Jul; 227(7):2917-26. PubMed ID: 21938726
[TBL] [Abstract][Full Text] [Related]
12. Impaired regulation of hepatic glucose production in mice lacking the forkhead transcription factor Foxo1 in liver.
Matsumoto M; Pocai A; Rossetti L; Depinho RA; Accili D
Cell Metab; 2007 Sep; 6(3):208-16. PubMed ID: 17767907
[TBL] [Abstract][Full Text] [Related]
13. The new biology of diabetes.
Pajvani UB; Accili D
Diabetologia; 2015 Nov; 58(11):2459-68. PubMed ID: 26248647
[TBL] [Abstract][Full Text] [Related]
14. SREBP-1c and TFE3, energy transcription factors that regulate hepatic insulin signaling.
Shimano H
J Mol Med (Berl); 2007 May; 85(5):437-44. PubMed ID: 17279346
[TBL] [Abstract][Full Text] [Related]
15. Hepatic FoxO1 integrates glucose utilization and lipid synthesis through regulation of Chrebp O-glycosylation.
Ido-Kitamura Y; Sasaki T; Kobayashi M; Kim HJ; Lee YS; Kikuchi O; Yokota-Hashimoto H; Iizuka K; Accili D; Kitamura T
PLoS One; 2012; 7(10):e47231. PubMed ID: 23056614
[TBL] [Abstract][Full Text] [Related]
16. Coordinated regulation of hepatic FoxO1, PGC-1α and SREBP-1c facilitates insulin action and resistance.
Sajan MP; Lee MC; Foufelle F; Sajan J; Cleland C; Farese RV
Cell Signal; 2018 Mar; 43():62-70. PubMed ID: 29269047
[TBL] [Abstract][Full Text] [Related]
17. Acute exercise reduces hepatic glucose production through inhibition of the Foxo1/HNF-4alpha pathway in insulin resistant mice.
De Souza CT; Frederico MJ; da Luz G; Cintra DE; Ropelle ER; Pauli JR; Velloso LA
J Physiol; 2010 Jun; 588(Pt 12):2239-53. PubMed ID: 20421289
[TBL] [Abstract][Full Text] [Related]
18. The adipokine sFRP4 induces insulin resistance and lipogenesis in the liver.
Hörbelt T; Knebel B; Fahlbusch P; Barbosa D; de Wiza DH; Van de Velde F; Van Nieuwenhove Y; Lapauw B; Thoresen GH; Al-Hasani H; Müller-Wieland D; Ouwens DM; Kotzka J
Biochim Biophys Acta Mol Basis Dis; 2019 Oct; 1865(10):2671-2684. PubMed ID: 31336149
[TBL] [Abstract][Full Text] [Related]
19. Hepatic FoxO1 ablation exacerbates lipid abnormalities during hyperglycemia.
Haeusler RA; Han S; Accili D
J Biol Chem; 2010 Aug; 285(35):26861-26868. PubMed ID: 20573950
[TBL] [Abstract][Full Text] [Related]
20. PEPCK1 Antisense Oligonucleotide Prevents Adiposity and Impairs Hepatic Glycogen Synthesis in High-Fat Male Fed Rats.
Beddow SA; Gattu AK; Vatner DF; Paolella L; Alqarzaee A; Tashkandi N; Popov VB; Church CD; Rodeheffer MS; Cline GW; Geisler JG; Bhanot S; Samuel VT
Endocrinology; 2019 Jan; 160(1):205-219. PubMed ID: 30445425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
